Compile Data Set for Download or QSAR
Report error Found 83 Enz. Inhib. hit(s) with all data for entry = 50011373
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546596(CHEMBL4741372)
Affinity DataEC50:  0.398nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546596(CHEMBL4741372)
Affinity DataEC50:  0.400nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 4(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546560(CHEMBL4778342)
Affinity DataEC50:  0.501nMAssay Description:Agonist activity at human SST4More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546560(CHEMBL4778342)
Affinity DataEC50:  0.501nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546590(CHEMBL4754720)
Affinity DataEC50:  1.20nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546561(CHEMBL4750168)
Affinity DataEC50:  1.20nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546561(CHEMBL4750168)
Affinity DataEC50:  1.30nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546590(CHEMBL4754720)
Affinity DataEC50:  1.30nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546588(CHEMBL4747697)
Affinity DataEC50:  1.58nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546588(CHEMBL4747697)
Affinity DataEC50:  1.60nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546589(CHEMBL4756956)
Affinity DataEC50:  3.20nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546575(CHEMBL4760476)
Affinity DataEC50:  3.20nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546575(CHEMBL4760476)
Affinity DataEC50:  3.20nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546589(CHEMBL4756956)
Affinity DataEC50:  3.40nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546577(CHEMBL4745767)
Affinity DataEC50:  3.80nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546577(CHEMBL4745767)
Affinity DataEC50:  4nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546573(CHEMBL4742147)
Affinity DataEC50:  6.10nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546574(CHEMBL4778857)
Affinity DataEC50:  6.30nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546573(CHEMBL4742147)
Affinity DataEC50:  6.30nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546574(CHEMBL4778857)
Affinity DataEC50:  6.31nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546591(CHEMBL4740611)
Affinity DataEC50:  7.40nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 3(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546560(CHEMBL4778342)
Affinity DataEC50:  7.90nMAssay Description:Agonist activity at human SST3More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546591(CHEMBL4740611)
Affinity DataEC50:  7.90nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546562(CHEMBL4741139)
Affinity DataEC50:  10nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546562(CHEMBL4741139)
Affinity DataEC50:  11nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546587(CHEMBL4800376)
Affinity DataEC50:  12.6nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546587(CHEMBL4800376)
Affinity DataEC50:  13nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546586(CHEMBL4748425)
Affinity DataEC50:  15nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546586(CHEMBL4748425)
Affinity DataEC50:  16nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546592(CHEMBL4800534)
Affinity DataEC50:  25nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546592(CHEMBL4800534)
Affinity DataEC50:  27nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546564(CHEMBL4782501)
Affinity DataEC50:  31nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546564(CHEMBL4782501)
Affinity DataEC50:  32nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546584(CHEMBL4760001)
Affinity DataEC50:  39.8nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546584(CHEMBL4760001)
Affinity DataEC50:  40nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546567(CHEMBL4799254)
Affinity DataEC50:  40nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546583(CHEMBL4749169)
Affinity DataEC50:  40nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546583(CHEMBL4749169)
Affinity DataEC50:  42nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546567(CHEMBL4799254)
Affinity DataEC50:  42nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546572(CHEMBL4758610)
Affinity DataEC50:  50nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546572(CHEMBL4758610)
Affinity DataEC50:  50nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546560(CHEMBL4778342)
Affinity DataEC50:  63nMAssay Description:Agonist activity at human N-terminal HA-tagged SST2 expressed in cell assessed as induction of receptor internalization by colorimetric analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546568(CHEMBL4752814)
Affinity DataEC50:  63nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546568(CHEMBL4752814)
Affinity DataEC50:  63.1nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546593(CHEMBL4777739)
Affinity DataEC50:  100nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546593(CHEMBL4777739)
Affinity DataEC50:  100nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546576(CHEMBL4784765)
Affinity DataEC50:  100nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546576(CHEMBL4784765)
Affinity DataEC50:  100nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546581(CHEMBL4744310)
Affinity DataEC50:  125nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
TargetSomatostatin receptor type 2(Human)
Crinetics Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50546581(CHEMBL4744310)
Affinity DataEC50:  126nMAssay Description:Agonist activity at human SST2 expressed in CHOK1 cells assessed as inhibition of NKH477-stimulated intracellular cAMP levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2022
Entry Details
PubMed
Displayed 1 to 50 (of 83 total ) | Next | Last >>
Jump to: